Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Treatments for melanin disorders exist, but more effective options needed.

Ethanol boosts brain steroid production by activating NMDA receptors, affecting memory formation.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Skin problems are very common in people with end-stage kidney disease.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Compartmentalized organization might be crucial for stem cells to effectively respond to growth or injury.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Drug addicts often have scars, skin color changes, blocked veins, and bruising, with severe ulcers from barbiturate injections.

Burn reconstruction improves with new techniques, materials, and tissue engineering.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.